ENANTA PHARMACEUTICALS INC shareholders Q3 2023

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 132 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.

ENANTA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 735,103$8,2113.02%
BRAIDWELL LP 1,038,310$11,597,9230.37%
ARMISTICE CAPITAL, LLC 2,100,000$23,457,0000.36%
FARALLON CAPITAL MANAGEMENT LLC 1,875,000$20,943,7500.10%
PDT Partners, LLC 67,318$751,9420.10%
Virtus ETF Advisers LLC 12,784$142,7970.09%
Portland Global Advisors LLC 34,175$3820.06%
XTX Topco Ltd 27,222$304,0700.05%
Trexquant Investment LP 132,561$1,480,7060.04%
SHERBROOKE PARK ADVISERS LLC 10,100$112,8170.04%
OCCUDO QUANTITATIVE STRATEGIES LP 24,253$270,9060.04%
Y-Intercept (Hong Kong) Ltd 31,247$349,0290.03%
CORNERCAP INVESTMENT COUNSEL INC 14,015$156,5480.03%
CAXTON ASSOCIATES LP 18,028$201,3730.03%
ACADIAN ASSET MANAGEMENT LLC 548,782$6,1250.03%
Jump Financial, LLC 56,636$632,6240.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 345,651$3,860,9220.02%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 92,283$8,5140.02%
Assenagon Asset Management S.A. 631,626$7,055,2620.02%
GSA CAPITAL PARTNERS LLP 23,058$2580.02%
External links

This page lists ENANTA PHARMACEUTICALS INC's shareholders in Q3 2023. To view ENANTA PHARMACEUTICALS INC's shareholder history, click here.